Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Selective Retina Therapy (SRT) in Patients With Idiopathic Central Serous Chorioretinopathy: A Prospective Randomized Controlled Trial

NCT00987077 is registered in ClinicalTrials.gov with University of Kiel as lead sponsor.

NCT NCT00987077
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00987077 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Selective Retina Therapy (SRT) in Patients With Idiopathic Central Serous Chorioretinopathy: A Prospective Randomized Controlled Trial
Lead sponsor
University of Kiel
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2007
Completion date
January 31, 2009
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

central serous chorioretinopathy, selective retina therapy